Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriophage Therapy in Orthopedic Implant-Associated Infections
NCT07533292Phase 3Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in orthopedic implant-associated infection (PJI), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Bacterial eradication rate after bacteriophage therapy at 7 days. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
orthopedic implant-associated infection (PJI)
Beyond the preview
Go deeper on NCT07533292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07533292.